Thieler Law Corp advises investors with losses exceeding $100,000 of the September 22, 2015 lead plaintiff deadline in a class action lawsuit filed against XOMA Corporation (NASDAQ: XOMA) (“XOMA Corp” or “the Company”). The suit is pending in the U.S. District Court for the Northern District of California and investors, who purchased XOMA Corp securities between November 6, 2014 and July 21, 2015, have until September 22, 2015 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased XOMA Corp securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 866-6157 or emailing mail@thielerlaw.com .  No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements that Xoma Corporation’s EYEGUARD-B clinical trial would succeed and/or exceed projections across the study’s primary endpoint.

On July 22, 2015, XOMA Corp announced that the Phase 3 EYEGUARD-B study had failed. After this announcement, NASDAQ: XOMA stock declined by $3.48 per share, or more than 79%, on extremely heavy trading volume.

If you were negatively impacted by your investment in XOMA Corp securities between November 6, 2014 and July 21, 2015 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185